These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Deficiency of Tregs in hypertension-associated left ventricular hypertrophy. Tang Y; Shen L; Bao JH; Xu DY J Clin Hypertens (Greenwich); 2023 Jun; 25(6):562-572. PubMed ID: 37196041 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530 [TBL] [Abstract][Full Text] [Related]
24. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia. Nunes PR; Romão-Veiga M; Peraçoli JC; Araujo Costa RA; de Oliveira LG; Borges VTM; Peraçoli MT Immunol Res; 2019 Jun; 67(2-3):194-201. PubMed ID: 31240481 [TBL] [Abstract][Full Text] [Related]
25. Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapy. Mizuno R; Fujimoto S; Saito Y; Yamazaki M Heart; 2016 Jun; 102(11):849-54. PubMed ID: 26839069 [TBL] [Abstract][Full Text] [Related]
26. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study. Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM; Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947 [TBL] [Abstract][Full Text] [Related]
27. Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients. Su Z; Tian S; Liang W Cardiovasc Ther; 2019; 2019():4183781. PubMed ID: 31772610 [TBL] [Abstract][Full Text] [Related]
28. Morphologic and Functional Heart Abnormalities Associated to High Modified Tei Index in Hypertensive Patients. Tissera G; Piskorz D; Citta L; Citta N; Citta P; Keller L; Bongarzoni L; Mata L; Tommasi A High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):373-380. PubMed ID: 27623974 [TBL] [Abstract][Full Text] [Related]
29. Clinical correlates of left ventricular hypertrophy in black patients with arterial hypertension. Lepira FB; Kayembe PK; M'buyamba-Kabangu JR; Nseka MN Cardiovasc J S Afr; 2006; 17(1):7-11. PubMed ID: 16547554 [TBL] [Abstract][Full Text] [Related]
30. Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm. Rubio-Navarro A; Amaro Villalobos JM; Lindholt JS; Buendía I; Egido J; Blanco-Colio LM; Samaniego R; Meilhac O; Michel JB; Martín-Ventura JL; Moreno JA Int J Cardiol; 2015 Dec; 201():66-78. PubMed ID: 26296046 [TBL] [Abstract][Full Text] [Related]
31. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Ruilope LM; Schmieder RE Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140 [TBL] [Abstract][Full Text] [Related]
32. CD163 and CD206 expression does not correlate with tolerance and cytokine production in LPS-tolerant human monocytes. Alves-Januzzi AB; Brunialti MKC; Salomao R Cytometry B Clin Cytom; 2017 May; 92(3):192-199. PubMed ID: 26352275 [TBL] [Abstract][Full Text] [Related]
33. CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients. Greco R; Demartini C; Zanaboni AM; Tumelero E; Persico A; Candeloro E; Morotti A; Amantea D; Tassorelli C Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201498 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of irbesartan versus amlodipine on left ventricular mass index in hypertensive patients with left ventricular hypertrophy. Gaudio C; Ferri FM; Giovannini M; Pannarale G; Puddu PE; Vittore A; Fera MS; Vizza CD; Fedele F J Cardiovasc Pharmacol; 2003 Nov; 42(5):622-8. PubMed ID: 14576510 [TBL] [Abstract][Full Text] [Related]
35. Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression. Cohen A; Bregman B; Agabiti Rosei E; Williams B; Dubourg O; Clairefond P; Brudi P; Gosse P; Guéret P J Hum Hypertens; 1998 Jul; 12(7):479-83. PubMed ID: 9702935 [TBL] [Abstract][Full Text] [Related]
36. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA). Malmqvist K; Kahan T; Edner M; Bergfeldt L Am J Cardiol; 2002 Nov; 90(10):1107-12. PubMed ID: 12423712 [TBL] [Abstract][Full Text] [Related]
37. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis. Bayés-Genís A; Guindo J; Viñolas X; Tomás L; Elosua R; Duran I; Bayés de Luna A Am J Cardiol; 1995 Nov; 76(13):54D-59D. PubMed ID: 7495219 [TBL] [Abstract][Full Text] [Related]